Target intelligence / Profile preview

novel transcript, antisense to METTL2B

Molecular classification
Other
01

Overview

This entry refers to a "novel transcript" that is antisense to the METTL2B gene (Methyltransferase like 2B), based on its Ensembl identifier ENSG00000302221. There is no evidence that this transcript encodes a functional protein, nor is it classified as a therapeutic target such as a receptor, enzyme, transporter, or ion channel. The designation suggests an uncharacterized non-coding RNA running in the opposite genomic direction to the METTL2B gene. There are currently no data on its biological function, molecular pathway, disease involvement, drug interactions, or clinical utility. For information on METTL2B itself, refer to canonical entry for N3-methylcytidine methyltransferase 2B, a tRNA-modifying methyltransferase with some emerging evidence of a role in cancer biology.

Beyond the preview

Go deeper on novel transcript, antisense to METTL2B.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on novel transcript, antisense to METTL2B.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call